Wedbush analyst David Nierengarten maintained a Buy rating on AnaptysBio (ANAB – Research Report) today and set a price target of $40.00. The ...

In a report released today, Laura Chico from Wedbush maintained a Buy rating on Neurocrine (NBIX – Research Report), with a price target of ...

Take-Two Interactive Software forecast its fourth-quarter bookings below estimates on Thursday, owing to weaker spending on ...

Advanced Micro Devices (NASDAQ:AMD – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Wedbush in a research report issued on Wednesday,RTT News reports. They currently have a $150.00 ...

Looking ahead, IDC estimates AI platform sales will increase at 40% annually to reach $153 billion by 2028. Palantir ...

Charles Schwab Trust Co trimmed its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 22.0% during the fourth quarter, ...

We recently published a list of 10 Must-Watch AI Stocks Dominating Headlines. In this article, we are going to take a look at ...

Fintel reports that on February 6, 2025, Wedbush initiated coverage of Bicara Therapeutics (NasdaqGM:BCAX) with a Outperform ...

Since Palantir reported results, Yahoo Finance data shows there have been several upward revisions to EPS expectations for ...

Revenue: Analysts tracked by FactSet expect $187.3 billion in revenue, up from $170.0 billion a year before. The FactSet consensus calls for 8.6% growth in North America revenue to $114.6 billion, 9.7 ...

Palantir trades at valuations such that the stock still looks richly valued even after hyperbolic growth in its business.

Roblox stock is down Thursday after the gaming company came up short on key metrics for its fourth quarter. Here's what you ...